Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Dick Van Dyke shares his secrets to longevity as he turns 100 - 2What’s your chronotype? Knowing whether you’re a night owl or an early bird could help you do better on tests and avoid scams
- 3Hilary Duff releases 'Mature,' her 1st song in 10 years
- 4Vote In favor of Your Favored Language Learning Applications
- 5Social Skylines d: A Survey of \Inside and out Social Experiences\ Language Learning Book
- Figure out how to Arrange a Fair Settlement with the Assistance of a Fender bender Legal counselor
- Simple Consideration Plants for Home and Office: An Aide
- Step by step instructions to Appropriately Keep up with Your Sunlight powered chargers for Most extreme Productivity
- Watching ‘Home Alone’ with the kids this holiday season? Brace yourself for '6-7.'
- Moving Pool Highlights for 2024
- Well known SUVs With Low Energy Utilization In 2024 vote
- See the famous winged horse Pegasus fly in the autumn night sky
- A Texas GOP congressman is retiring. Trump just endorsed his identical twin to replace him.
- Why some African countries are prone to military takeovers
